Free Trial

TScan Therapeutics (TCRX) SEC Filings & 10K Form

TScan Therapeutics logo
$1.42 +0.10 (+7.20%)
As of 02:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent TScan Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
3:40 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
TScan Therapeutics (Subject)
Form SCHEDULE 13G/A
05/15/2025
1:19 PM
EcoR1 Capital, LLC (Filed by)
TScan Therapeutics (Subject)
Form SCHEDULE 13G/A
05/14/2025
6:01 AM
TScan Therapeutics (Filer)
Form DEF 14A
05/14/2025
6:05 AM
TScan Therapeutics (Filer)
Form DEFA14A
05/14/2025
6:11 AM
TScan Therapeutics (Filer)
Form ARS
05/06/2025
6:15 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
6:30 AM
TScan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2025
8:12 AM
BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
Form SCHEDULE 13G/A
03/16/2025
11:15 PM
TScan Therapeutics (Filer)
Form EFFECT
03/05/2025
3:28 PM
TScan Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/05/2025
6:30 AM
TScan Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2025
6:15 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
8:00 AM
Lynx1 Capital Management LP (Filed by)
TScan Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
8:38 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
TScan Therapeutics (Subject)
Form SCHEDULE 13G/A
02/11/2025
4:47 PM
Louis Chrystal (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
4:47 PM
Amello Jason (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
4:52 PM
MacBeath Gavin (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
4:54 PM
Dworak Leiden (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
4:54 PM
TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:15 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
6:15 AM
TScan Therapeutics (Filer)
Form 424B5
12/26/2024
6:30 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
6:27 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
3:26 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
7:14 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
7:05 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2024
3:26 PM
Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
2:05 PM
Cormorant Asset Management, LP (Filed by)
TScan Therapeutics (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
Form SC 13G
11/01/2024
6:00 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
TScan Therapeutics (Subject)
Form SC 13G
09/24/2024
4:26 PM
Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
5:46 PM
TScan Therapeutics (Issuer)
ZDRAVESKI ZORAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
5:57 PM
Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:50 PM
TScan Therapeutics (Subject)
ZDRAVESKI ZORAN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
6:30 AM
TScan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
6:15 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:20 PM
Nicholson Garry A (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:20 PM
Gruia Gabriela (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:20 PM
Klencke Barbara (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:20 PM
Dorton Katina (Reporting)
TScan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The DOJ Just Said Your Money Isn’t Yours (Ad)

What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.

Get your free guide now by clicking here >>
06/14/2024
3:20 PM
TScan Therapeutics (Issuer)
Woods Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:15 AM
TScan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TCRX) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners